Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
Medical Device Network on MSN
Co-Dx to form JV with Arabian Eagle for PCR platform distribution
Co-Dx will equip the JV with an exclusive licence to utilise, produce, and market the licensed intellectual property.
Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of ...
Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a ...
GlobalData on MSN
Biodesix and Bio-Rad expand collaboration for IVD assays development
Biodesix has expanded its collaboration with Bio-Rad Laboratories for the development and clinical validation of in vitro diagnostic (IVD) assays, designed to facilitate the identification of a ...
Countable Labs has launched Countable 10, a PCR instrument capable of detecting 10 distinct fluorophores within a single reaction.
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
News-Medical.Net on MSN
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays
Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement ...
The polymerase chain reaction (PCR) capitalizes on this biological toolbox by manufacturing millions of copies of desired piece of DNA. Invented in 1985 by Kary Mullis, Henry Erlich, and their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback